Zobrazeno 1 - 10
of 661
pro vyhledávání: '"C. Dejaco"'
Publikováno v:
Reumatismo (2024)
The objective of this case series is to describe the efficacy and safety of baricitinib (BARI) in a group of patients with polymyalgia rheumatica (PMR) and/or giant cell arteritis (GCA). These patients were treated with BARI due to either a refractor
Externí odkaz:
https://doaj.org/article/0d8e4c9704c74da2a559a1fb67b562fe
Autor:
D. Camellino, C. Dejaco
Publikováno v:
Reumatismo, Vol 70, Iss 1, Pp 59-66 (2018)
Polymyalgia rheumatica (PMR) is the second most common inflammatory rheumatic disease in the elderly after rheumatoid arthritis. It is clinically characterised by pain and stiffness in the neck, proximal shoulder and hip girdle. Glucocorticoids (GCs)
Externí odkaz:
https://doaj.org/article/e5e85b76d01840d6b250649407f27508
Publikováno v:
ISPRS Annals of the Photogrammetry, Remote Sensing and Spatial Information Sciences, Vol VI-4-W1-2020, Pp 77-84 (2020)
The integration of Building Information Modelling (BIM) and Geographical Information Systems (GIS) is gaining momentum in digital built Asset Management (AM), and has the potential to improve information management operations and provide advantages i
Externí odkaz:
https://doaj.org/article/7f08c8dee94c4c14830abcd9572eef43
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Zeitschrift für Rheumatologie. 79:523-531
Die Riesenzellarteriitis (RZA) und die Takayasu-Arteriitis (TAK) zahlen zu den Grosgefasvaskulitiden und erfordern eine langfristige medikamentose Therapie. Bei beiden Erkrankungen ist die Behandlung mit Glukokortikoiden (GC) erste Wahl, bei der RZA
Publikováno v:
Seminars in arthritis and rheumatism. 56
The aim of this observational study was to compare clinical outcomes including glucocorticoid treatment and relapses between giant cell arteritis (GCA) patients with (axGCA) and without axillary artery involvement (non-axGCA).Axillary artery ultrasou
Autor:
C. Dejaco, I. Gessl, R. Husic, T. Deimel, A. Lackner, G. Supp, J. Hermann, J. S. Smolen, M. Stradner, D. Aletaha, G. Schwantzer, P. Mandl
Publikováno v:
Annals of the Rheumatic Diseases. 81:1035-1036
BackgroundDiscontinuation of biological (b)DMARDs may be considered in rheumatoid arthritis (RA) patients in persistent clinical remission [1]. Some earlier studies reported that baseline ultrasound may predict successful tapering or withdrawal of bD
Autor:
P. Mandl, I. Gessl, G. Filippou, S. Sirotti, L. Terslev, C. Pineda, H. Keen, M. Backhaus, D. A. Bong, E. Cipolletta, P. Collado, C. Dejaco, A. Delle Sedie, C. Duftner, H. B. Hammer, A. Iagnocco, Z. Karim, I. Möller, E. Naredo, W. A. Schmidt, M. Szkudlarek, G. Tamborrini, P. C. Wong, E. Filippucci, P. Balint, M. A. D’Agostino
Publikováno v:
Annals of the Rheumatic Diseases. 81:193-194
BackgroundStructural damage in rheumatoid arthritis (RA) includes bone erosion, cartilage change, and joint malalignment; historically evaluated with conventional radiography. Ultrasound (US) has been shown to be a valid tool for evaluating both cart
Autor:
A. Overgaard Donskov, S. Mackie, E. M. Hauge, C. Toro Gutiérrez, I. Hansen, A. Hemmig, A. Van der Maas, T. A. Gheita, B. Dalsgaard Nielsen, K. Douglas, R. Conway, E. Rezus, B. Dasgupta, S. Monti, E. Matteson, S. E. Sattui, M. Matza, V. Ocampo, A. Bran, S. Appenzeller, A. Goecke, N. Colman MC Leod, H. Keen, M. Kuwana, L. Gupta, B. Salim, G. Harifi, M. Erraoui, N. Ziade, N. A. Al-Ani, A. Ajibade, J. Knitza, L. Frølund, M. Yates, V. Pimentel-Quiroz, A. Lyrio, M. Sandovici, K. Van der Geest, T. Helliwell, E. Brouwer, C. Dejaco, K. Keller
Publikováno v:
Annals of the Rheumatic Diseases. 81:1417-1418
BackgroundPolymyalgia rheumatica (PMR) is diagnosed and treated by both general practitioners (GP) and rheumatologists. How rheumatologists around the world manage the referral process of patients with PMR from GP’s has not been described. EULAR/AC
Autor:
A. Marques, P. Bosch, A. De Thurah, Y. Meissner, L. Falzon, C. Mukhtyar, H. Bijlsma, C. Dejaco, T. Stamm
Publikováno v:
Annals of the Rheumatic Diseases. 81:444.1-445
BackgroundWhile the number of patients with rheumatic musculoskeletal diseases (RMDs) is increasing worldwide, there is no adequate increment in the number of health care professionals, leading to the urgent need for new forms of care to take pressur